SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,975.00    525.00 (11.80%)
Bid:
4,900.00
Ask:
5,050.00
Spread: 150.00 (3.061%)
Market Cap: £331.37m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Acquisition

5 Sep 2005 13:25

Judges Capital PLC05 September 2005 5 September 2005 Judges Capital plc ("Judges Capital" or the "Company") Judges Capital acquires controlling interest in PE fiberoptics Ltd The Directors of Judges Capital announce that, on 2 September 2005, the Companycompleted the acquisition of a controlling interest in PE fiberoptics Ltd ("PEf"), a Management Buy Out ("MBO") vehicle that will specialise in the designand manufacture of instruments used to test fibreoptic telecommunicationscables. PEf is a private company newly established to effect the acquisition from a USmultinational corporation (the "Vendor") of the business, assets and goodwill ofa fibreoptic test equipment operation based in Wokingham, Berkshire forUS$100,000. Judges Capital has invested a nominal sum in exchange for 51% of PEf's equityand is providing loan and working capital commitments of £291,000 (of which£250,000 is secured) from the Company's existing resources. The interests of thekey management team participating in the MBO and providing further loans of£28,000 amount to 35%. The balance of 14% of PEf's equity is held by the Vendor. The operation generated turnover of £1.1million and an unaudited loss beforeinterest, tax, depreciation, amortisation, rent, pensions and corporate charges("Adjusted Ebitda") of £1 million for the year ended 31 December 2004. Theoperation achieved historic sales of $22 million and unaudited Adjusted Ebitdaof $11 million for the year ended 31 December 2001 as a result of the 'dot com'exuberance but subsequently experienced a drastic downturn in revenues in linewith its technology related client base. The operation was closed by the Vendorin June 2005. The net assets purchased had a value of around £1.5 million in thebooks of the Vendor. David Cicurel, Chief Executive of Judges Capital, commented: "We are delighted to have reached agreement with the ongoing management team inrelation to the MBO of PE fiberoptics. As stated at the time of our acquisitionof Fire Testing Technology earlier this year, the Board of Judges Capital hasidentified instrumentation and testing as an area that the Directors believeoffers significant potential for growth and enhanced shareholder returns. Wehave every confidence that, in partnership with PE fiberoptic's experiencedmanagement team, led by Ian Mackenzie, Managing Director, we will succeed inpositioning the company to take full advantage of opportunities and therebycapitalise on the acknowledged expertise inherent in the business." Ends For further information please contact: David Cicurel, Chief Executive, Judges Capital: Tel: 07771 893 080Alex Borrelli, Shore Capital & Corporate: Tel: 020 7408 4090Melvyn Marckus, Cardew Group: Tel: 0207 930 0777 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jan 20219:31 amRNSGrant of Options
7th Jan 20212:30 pmRNSDirector/PDMR Shareholding
7th Jan 20217:00 amRNSTrading Statement and Notice of Final Results
31st Dec 20207:00 amRNSTotal Voting Rights
10th Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Nov 20207:00 amRNSBlock listing Interim Review
12th Nov 20207:00 amRNSCORRECTION: Director/PDMR Shareholding
11th Nov 20204:48 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSGrant of Options
26th Oct 20205:16 pmRNSExercise of Options and Director Dealing
19th Oct 20204:38 pmRNSDirector/PDMR Shareholding
19th Oct 20207:00 amRNSAcquisition of Korvus Technology Ltd
7th Oct 20209:33 amRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSInterim Results
16th Sep 20202:17 pmRNSHolding(s) in Company
10th Sep 202011:25 amRNSDirector/PDMR Shareholding
10th Sep 20207:00 amRNSBoard Change
1st Sep 20209:48 amRNSTotal Voting Rights
11th Aug 20208:24 amRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
21st Jul 20207:00 amRNSTrading Update and Notice of Interim Results
7th Jul 20202:28 pmRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSTotal Voting Rights
8th Jun 20204:03 pmRNSDirector/PDMR Shareholding
2nd Jun 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSAcquisition of Heath Scientific Company Limited
20th May 20201:55 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Update
15th May 20208:53 amRNSBlock listing Interim Review
14th May 20209:52 amRNSAGM Q&A
7th May 20209:59 amRNSDirector/PDMR Shareholding
30th Apr 20209:52 amRNSTotal Voting Rights
28th Apr 20207:00 amRNSNotice of AGM
8th Apr 202010:23 amRNSDirector/PDMR Shareholding
31st Mar 202011:10 amRNSTotal Voting Rights
18th Mar 20207:00 amRNSFinal Results
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
10th Mar 20208:55 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSStatement regarding COVID-19
7th Feb 20207:00 amRNSDirector/PDMR Shareholding
31st Jan 202010:46 amRNSBlocklisting Application and Total Voting Rights
16th Jan 20203:18 pmRNSExercise of Options and Director Dealing
16th Jan 20207:00 amRNSTrading Statement and Notice of Final Results
13th Jan 20209:37 amRNSDirector/PDMR Shareholding
2nd Jan 20201:42 pmRNSTotal Voting Rights
18th Dec 20198:49 amRNSHolding(s) in Company
6th Dec 20193:01 pmRNSDirector/PDMR Shareholding
6th Dec 20192:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.